Wearable Devices and Tax-Favored Accounts: IRS Clarifies When the Cost Is a Medical Expense
By: HUB's EB Compliance Team
Smartwatches, fitness bands, smart rings, and similar wearable devices have grown in popularity over the last several years. As a result, individuals increasingly request reimbursement for these devices under health savings accounts ("HSAs"), health flexible spending accounts ("health FSAs"), and health reimbursement arrangements ("HRAs"). Recently, the Internal Revenue Service ("IRS") added a new question ("Q15") to its existing Frequently Asked Questions About Medical Expenses Related to Nutrition, Wellness, and General Health, squarely addressing when the cost of a wearable device qualifies as a reimbursable medical expense.
The guidance confirms that tracking health-related data alone does not make a device an eligible expense and outlines the facts-and-circumstances inquiry that plan sponsors and administrators should apply when evaluating a reimbursement request. Because these devices are heavily marketed as health products, plan sponsors should understand the standard before fielding more employee reimbursement requests.
Regulatory Background: Section 213 and the General-Health Exclusion
Only expenses for "medical care" under Section 213 of the Internal Revenue Code (the "Code"), are eligible to be reimbursed under an HSA, health FSA, or HRA. Medical care reimbursements under the section are limited to amounts paid for the diagnosis, cure, mitigation, treatment, or prevention of disease, or for the purpose of affecting any structure or function of the body. The applicable Treasury Regulation narrows this further: an expense must be primarily for preventing or alleviating a physical or mental defect or illness. Expenses that merely benefit an individual's general health, without that primary medical care purpose, do not qualify for reimbursement.
In March 2023, the IRS published FAQs addressing items such as nutritional counseling and weight-loss programs. The IRS concluded that such expenses are medical care under Section 213 only when they treat a specific, diagnosed condition rather than general wellness. Q15 extends that same framework to wearable devices.
The New Guidance: Q15 and the Wearable Device Test
Q15 applies to bands, watches, rings, patches, sensors, and similar devices that track bodily functions or other health-related information, confirming that whether such a device's cost qualifies as a medical expense depends on all the facts and circumstances, including the device's functions and the reason for its purchase and use.
A device with both medical and nonmedical uses — such as tracking, general wellness, fitness, or sleep, along with other personal uses — is not a medical expense merely because it tracks health-related data. This is true even if it tracks bodily functions like blood pressure or blood glucose that can be affected by specific diseases. A generalized desire to monitor or improve one's own health is not a sufficient basis for reimbursement under Q15. Thus, the cost of a wearable device qualifies as a reimbursable medical expense if the individual purchases and uses the device primarily to assist in the diagnosis, cure, mitigation, treatment, or prevention of a specific disease. Relevant facts and circumstances for making that determination, as identified in Q15 include:
- A recommendation from a medical practitioner;
- The individual's symptoms, diagnosis, abnormal test results, or risk factors;
- The relationship between the information the device tracks and the disease being evaluated or managed; and
- How the information is actually reviewed or used.
Likewise, the cost of accessories, add-ons, or software subscriptions used with a device is an eligible medical expense only if those items are also purchased primarily for the same medical purpose.
Q15, like the rest of the FAQ series, is sub-regulatory guidance posted on IRS.gov rather than a Treasury regulation or revenue ruling published in the Internal Revenue Bulletin. The IRS has stated that such FAQs are not binding legal authority or precedent. That said, if the IRS later determines a reimbursement was a non-qualified expense, a plan administrator's good-faith, reasonable reliance on Q15 would be a relevant factor in a reasonable-cause defense against accuracy-related penalties of up to 20% under IRC §6662. Employers should treat Q15 as the IRS's current enforcement position, while recognizing that it does not carry the weight of a regulation.
Implications for Plan Sponsors and Administrators
Q15 confirms what many third-party administrators ("TPAs") have already concluded and applied in practice: a wearable device is not automatically reimbursable simply because an employee submits a claim for it. Without documentation connecting the device to a specific disease or condition, a device marketed for "general wellness" or "fitness tracking" is the type of dual-use, personal-benefit item Q15 describes as ineligible for reimbursement on its own. The claim may be denied unless the employee provides facts or evidence establishing the device's required medical purpose.
Letters of Medical Necessity. Many TPAs require a letter of medical necessity ("LMN") from a medical practitioner that connects the device to a diagnosed condition before approving a wearable device claim. An LMN is not required by Q15 — the FAQ frames the inquiry around facts and circumstances rather than mandating specific documentation — but requiring one is a common and defensible practice for substantiating the medical-purpose determination and many plan sponsors find it the most practical way to apply the standard consistently.
Substantiation. Health FSA and HRA claims generally must be verified through independent third-party substantiation, such as an explanation of benefits or an itemized receipt. For HSA distributions, where the account holder self-certifies eligibility, the employer's compliance role is more limited, but employee communications addressing the standard remain useful: an account holder who takes an HSA distribution for a non-qualifying device may have the amount in gross income and subject to a 20% additional tax under the IRC.
Conclusion
Q15 does not change Section 213's underlying legal standard for medical expenses. Instead, it applies the longstanding, "primarily-for-treatment" test to an increasingly popular category of consumer product. Plan sponsors and administrators should expect continued growth in wearable device reimbursement requests and ensure claims procedures, documentation requirements, and employee communications all reference the facts-and-circumstances standard the IRS has articulated for this device category. Because Q15 is FAQ guidance rather than a published regulation, the IRS may still issue further clarification or formal guidance addressing specific device types.
If you have any questions, please contact your HUB Advisor. View more updates on HUB Resources.
NOTICE OF DISCLAIMER
Neither Hub International Limited nor any of its affiliated companies is a law or accounting firm, and therefore they cannot provide legal or tax advice. The information herein is provided for general information only and is not intended to constitute legal or tax advice as to an organization's or individual's specific circumstances. It is based on Hub International's understanding of the law as it exists on the date of this publication. Subsequent developments may result in this information becoming outdated or incorrect and Hub International does not have an obligation to update this information. You should consult an attorney, accountant, or other legal or tax professional regarding the application of the general information provided here to your organization's specific situation in light of your or your organization's particular needs.